Header Logo

Attila Nakeeb

Concepts (466)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreaticoduodenectomy
41
2022
62
5.260
Why?
Pancreatic Neoplasms
46
2023
331
4.330
Why?
Pancreatitis, Acute Necrotizing
23
2022
24
3.750
Why?
Pancreatectomy
36
2023
96
3.520
Why?
Carcinoma, Pancreatic Ductal
20
2023
106
2.200
Why?
Postoperative Complications
26
2023
1202
1.470
Why?
Laparoscopy
13
2021
427
1.350
Why?
Pancreatic Ducts
11
2020
30
1.310
Why?
Adenocarcinoma
15
2022
323
1.300
Why?
Drainage
15
2022
149
1.130
Why?
Retrospective Studies
76
2023
6071
1.120
Why?
Pancreatic Fistula
10
2021
18
1.060
Why?
Adenocarcinoma, Mucinous
9
2019
30
1.000
Why?
Intestinal Fistula
3
2020
10
0.900
Why?
Middle Aged
89
2022
16317
0.890
Why?
Duodenal Diseases
2
2020
14
0.860
Why?
Humans
138
2023
59360
0.820
Why?
Sphincter of Oddi Dysfunction
3
2023
3
0.810
Why?
Pancreatic Diseases
7
2015
39
0.810
Why?
Mesenteric Veins
2
2020
11
0.810
Why?
Female
111
2022
30705
0.790
Why?
Pancreatitis
6
2023
95
0.770
Why?
Aged
66
2022
13416
0.740
Why?
Gallbladder
12
2007
33
0.740
Why?
Male
93
2022
27739
0.740
Why?
Gallstones
3
2020
24
0.730
Why?
Patient Discharge
3
2023
489
0.720
Why?
Nomograms
1
2020
12
0.690
Why?
Pancreas
7
2019
147
0.680
Why?
Vascular Fistula
1
2020
8
0.680
Why?
Crohn Disease
2
2020
106
0.670
Why?
Stomach Neoplasms
1
2020
69
0.670
Why?
Adult
60
2022
15669
0.670
Why?
Patient Readmission
7
2023
420
0.660
Why?
Venous Thrombosis
5
2022
110
0.640
Why?
Cholangiocarcinoma
8
2012
27
0.600
Why?
Choledochostomy
1
2018
3
0.590
Why?
Common Bile Duct
1
2018
19
0.590
Why?
Duodenum
1
2018
42
0.580
Why?
Hepatectomy
7
2022
60
0.580
Why?
Pancreatic Cyst
6
2018
24
0.580
Why?
Treatment Outcome
36
2023
5284
0.560
Why?
Bile Duct Neoplasms
7
2012
42
0.560
Why?
Carcinoma, Papillary
6
2019
35
0.540
Why?
Incidence
19
2022
1237
0.530
Why?
Aged, 80 and over
31
2021
5128
0.490
Why?
Debridement
5
2022
30
0.480
Why?
Palliative Care
8
2017
214
0.470
Why?
Bile Ducts, Intrahepatic
6
2010
25
0.470
Why?
Digestive System Surgical Procedures
3
2023
88
0.460
Why?
Length of Stay
15
2021
775
0.450
Why?
Obesity
10
2022
1166
0.430
Why?
Gastroparesis
3
2019
8
0.420
Why?
Laparotomy
3
2021
47
0.410
Why?
Gallbladder Diseases
4
2007
26
0.410
Why?
Risk Factors
20
2023
4984
0.410
Why?
Survival Rate
16
2020
802
0.390
Why?
Blood Loss, Surgical
3
2018
57
0.360
Why?
Liver Diseases
2
2022
138
0.350
Why?
Neoplasm Invasiveness
12
2018
250
0.350
Why?
Indiana
10
2021
19
0.340
Why?
Tomography, X-Ray Computed
10
2020
1526
0.340
Why?
Bile
6
2019
19
0.330
Why?
Clinical Competence
3
2020
683
0.330
Why?
Surgical Wound Infection
4
2023
110
0.330
Why?
Pancreaticojejunostomy
3
2017
5
0.320
Why?
Sphincterotomy, Transduodenal
3
2023
4
0.320
Why?
Leptin
8
2006
83
0.320
Why?
Insulin Resistance
3
2007
392
0.310
Why?
Colorectal Neoplasms
2
2023
263
0.310
Why?
Cholelithiasis
4
2004
22
0.300
Why?
Muscle, Smooth
3
2019
137
0.300
Why?
Gastrostomy
3
2019
29
0.300
Why?
Biliary Tract Surgical Procedures
2
2010
12
0.290
Why?
Prognosis
12
2020
1600
0.290
Why?
Biliary Fistula
2
2020
4
0.290
Why?
Follow-Up Studies
14
2020
2337
0.280
Why?
Cholangiopancreatography, Endoscopic Retrograde
4
2023
46
0.270
Why?
Prospective Studies
12
2023
3067
0.270
Why?
Postoperative Care
3
2018
114
0.270
Why?
Splenic Artery
2
2020
8
0.270
Why?
Preoperative Care
7
2017
180
0.260
Why?
Gallbladder Neoplasms
1
2006
16
0.260
Why?
Hernia, Ventral
2
2020
25
0.260
Why?
Splenectomy
2
2019
41
0.260
Why?
Gallbladder Emptying
5
2006
5
0.250
Why?
Neuroendocrine Tumors
2
2019
21
0.250
Why?
Necrosis
6
2022
140
0.240
Why?
Logistic Models
6
2020
1232
0.230
Why?
Aneurysm, False
2
2020
46
0.230
Why?
Intestinal Obstruction
2
2020
49
0.230
Why?
Cholesterol
8
2007
252
0.230
Why?
Insulin
3
2006
674
0.220
Why?
Negative-Pressure Wound Therapy
1
2023
12
0.210
Why?
Biliary Tract Neoplasms
1
2002
8
0.200
Why?
Surgical Wound
1
2023
10
0.200
Why?
Pain, Postoperative
3
2022
141
0.200
Why?
Young Adult
11
2020
4267
0.200
Why?
Analgesia
1
2022
30
0.200
Why?
Cholangitis
2
2019
10
0.200
Why?
Pancreatitis, Chronic
3
2020
19
0.200
Why?
Neoplasm Staging
7
2017
452
0.200
Why?
Dilatation, Pathologic
2
2019
29
0.200
Why?
Cystadenoma, Mucinous
2
2017
5
0.190
Why?
Colonic Diseases
1
2022
34
0.190
Why?
Hyperamylasemia
1
2021
1
0.190
Why?
Adolescent
10
2020
5824
0.180
Why?
Cholangiopancreatography, Magnetic Resonance
2
2014
9
0.180
Why?
Patient Selection
7
2019
464
0.180
Why?
Disease Progression
4
2022
1122
0.180
Why?
Hypertriglyceridemia
1
2021
8
0.180
Why?
Internship and Residency
2
2020
746
0.180
Why?
Ursodeoxycholic Acid
1
2020
7
0.180
Why?
Portal Vein
2
2022
38
0.180
Why?
Surgical Mesh
1
2020
58
0.170
Why?
Lung Diseases
1
2022
170
0.170
Why?
Gastrectomy
1
2020
37
0.170
Why?
Pulmonary Embolism
2
2020
170
0.170
Why?
Wound Closure Techniques
1
2020
7
0.170
Why?
Anti-Bacterial Agents
4
2019
735
0.170
Why?
Leukocytosis
1
2019
11
0.170
Why?
Pancreatic Pseudocyst
1
2019
12
0.170
Why?
Amylases
2
2021
11
0.170
Why?
Peritoneal Lavage
1
2019
4
0.160
Why?
Sphincterotomy, Endoscopic
2
2023
7
0.160
Why?
Survivors
1
2020
149
0.160
Why?
Emergencies
1
2020
111
0.160
Why?
Nurse's Role
1
2020
116
0.160
Why?
Activins
1
2019
54
0.160
Why?
Positron-Emission Tomography
3
2015
200
0.160
Why?
Constriction, Pathologic
4
2020
112
0.160
Why?
Gastrointestinal Hemorrhage
1
2020
78
0.160
Why?
Lipase
2
2021
48
0.160
Why?
Biliary Tract Diseases
1
2019
16
0.160
Why?
Workload
1
2019
118
0.160
Why?
Stomach
1
2019
83
0.160
Why?
Deoxycytidine
2
2017
40
0.160
Why?
Analgesia, Epidural
1
2019
28
0.160
Why?
Time Factors
9
2019
3617
0.160
Why?
BRCA2 Protein
1
2019
13
0.160
Why?
Cholecystokinin
4
2006
9
0.150
Why?
Clostridium Infections
1
2019
45
0.150
Why?
DNA Fingerprinting
1
2018
6
0.150
Why?
Alcohol-Related Disorders
1
2019
35
0.150
Why?
Dietary Carbohydrates
3
2007
58
0.150
Why?
Travel
1
2018
37
0.150
Why?
Cholecystectomy
3
2007
31
0.150
Why?
Practice Patterns, Physicians'
3
2022
687
0.150
Why?
Enteral Nutrition
2
2019
54
0.150
Why?
BRCA1 Protein
1
2019
54
0.150
Why?
Thrombosis
1
2020
182
0.150
Why?
Cholestasis
2
1996
53
0.150
Why?
Surgeons
1
2021
161
0.150
Why?
Gastric Bypass
1
2019
74
0.150
Why?
Survival Analysis
6
2015
555
0.150
Why?
Perioperative Care
1
2019
76
0.150
Why?
Choledocholithiasis
1
2018
4
0.150
Why?
Analgesics
1
2019
96
0.150
Why?
Cross Infection
1
2019
149
0.150
Why?
Ambulatory Care
1
2020
300
0.140
Why?
Liver Neoplasms
1
2020
277
0.140
Why?
Gastric Mucosa
1
2017
51
0.140
Why?
Medical History Taking
1
2017
65
0.140
Why?
Neoplasm Recurrence, Local
2
2020
300
0.140
Why?
Cholecystitis
2
2007
27
0.140
Why?
Peripheral Nerves
1
2017
30
0.140
Why?
Hepatic Duct, Common
1
2017
7
0.140
Why?
Patient Care Team
2
2017
326
0.140
Why?
Jejunum
1
2017
14
0.140
Why?
Abdominal Pain
1
2018
94
0.140
Why?
Venous Thromboembolism
1
2019
141
0.140
Why?
Cancer Pain
1
2017
15
0.140
Why?
Carcinoembryonic Antigen
2
1999
32
0.140
Why?
Proton Pump Inhibitors
2
2015
34
0.140
Why?
Patient Safety
1
2019
237
0.140
Why?
Anastomotic Leak
1
2017
33
0.130
Why?
Liver Cirrhosis
1
2018
163
0.130
Why?
Embolization, Therapeutic
1
2020
308
0.130
Why?
Antimetabolites, Antineoplastic
1
2017
39
0.130
Why?
Chemoradiotherapy
1
2017
49
0.130
Why?
Radiotherapy
1
2017
62
0.130
Why?
Patient Education as Topic
1
2020
453
0.130
Why?
Diagnosis, Differential
6
2020
937
0.130
Why?
Blood Glucose
7
2007
461
0.130
Why?
Inpatients
1
2018
291
0.130
Why?
Databases, Factual
5
2018
813
0.130
Why?
Sphincter of Oddi
3
2019
4
0.130
Why?
Neoplasms, Multiple Primary
1
2015
29
0.130
Why?
Fellowships and Scholarships
1
2017
98
0.130
Why?
Lipoma
1
2015
16
0.130
Why?
Gene Expression Profiling
1
2019
718
0.130
Why?
Biomarkers, Tumor
4
2014
461
0.120
Why?
Adenocarcinoma, Papillary
1
2015
9
0.120
Why?
Financing, Organized
1
2015
16
0.120
Why?
Surgical Stapling
1
2015
12
0.120
Why?
Anti-Ulcer Agents
1
2015
8
0.120
Why?
Intubation, Gastrointestinal
3
2021
20
0.120
Why?
CA-19-9 Antigen
3
2014
10
0.120
Why?
Publications
1
2015
28
0.120
Why?
Common Bile Duct Neoplasms
1
1995
5
0.120
Why?
Peptic Ulcer
1
2015
20
0.120
Why?
Splenic Vein
1
2014
2
0.120
Why?
Ampulla of Vater
1
1995
12
0.120
Why?
Hyperlipidemias
2
2006
34
0.120
Why?
Lymph Node Excision
2
2006
38
0.120
Why?
Cystadenoma, Serous
2
2005
4
0.120
Why?
Adenoma
1
2014
64
0.110
Why?
Liver Abscess, Pyogenic
1
2014
1
0.110
Why?
Lipids
2
2007
300
0.110
Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2014
4
0.110
Why?
Health Services Accessibility
1
2018
521
0.110
Why?
Autoimmune Diseases
1
2015
220
0.110
Why?
Mutation
2
2019
2456
0.110
Why?
Parasympatholytics
1
2013
6
0.110
Why?
Continuity of Patient Care
1
2015
170
0.110
Why?
Genetic Predisposition to Disease
3
2023
676
0.110
Why?
Antidepressive Agents, Tricyclic
1
2013
19
0.110
Why?
Ultrasonography
3
2020
459
0.110
Why?
Predictive Value of Tests
5
2020
1025
0.110
Why?
Faculty, Medical
1
2015
192
0.110
Why?
Precancerous Conditions
1
2014
70
0.110
Why?
Catheter Ablation
1
2015
145
0.110
Why?
Bile Ducts
1
2012
21
0.100
Why?
Animals
18
2019
19651
0.100
Why?
Deep Sedation
1
2012
4
0.100
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2022
406
0.100
Why?
Body Mass Index
3
2019
831
0.100
Why?
Body Weight
7
2007
368
0.100
Why?
Disease-Free Survival
4
2016
228
0.100
Why?
Mice, Inbred C57BL
10
2007
3231
0.100
Why?
Smoking
1
2016
826
0.100
Why?
Liver
3
2012
797
0.090
Why?
Natural Orifice Endoscopic Surgery
1
2012
37
0.090
Why?
Antineoplastic Agents
1
2017
631
0.090
Why?
Nitric Oxide Synthase
2
2001
45
0.090
Why?
Anemia, Iron-Deficiency
2
2001
20
0.090
Why?
Chi-Square Distribution
4
2019
409
0.090
Why?
Neoadjuvant Therapy
2
2022
72
0.090
Why?
Reoperation
3
2019
272
0.090
Why?
Crystallization
6
2007
97
0.090
Why?
Mice
13
2019
10292
0.090
Why?
Sensitivity and Specificity
3
2018
1093
0.090
Why?
Anastomosis, Surgical
3
2020
107
0.090
Why?
Treatment Failure
2
2020
185
0.080
Why?
Robotics
1
2010
69
0.080
Why?
Dietary Fats
2
2007
173
0.080
Why?
Social Class
1
2010
122
0.080
Why?
Endosonography
3
2017
26
0.080
Why?
Receptor, Platelet-Derived Growth Factor alpha
2
2019
18
0.080
Why?
Bile Ducts, Extrahepatic
2
2006
3
0.080
Why?
Combined Modality Therapy
3
2017
355
0.080
Why?
Operative Time
2
2019
76
0.080
Why?
Lipid Metabolism
2
2007
203
0.080
Why?
Cholesterol, Dietary
2
2006
28
0.070
Why?
Adipose Tissue
2
2007
283
0.070
Why?
Risk Assessment
5
2019
1921
0.070
Why?
Proportional Hazards Models
3
2019
674
0.070
Why?
Cholangitis, Sclerosing
2
1999
12
0.070
Why?
Dinoprostone
1
2007
44
0.070
Why?
Azetidines
1
2007
7
0.070
Why?
Morbidity
2
2020
112
0.070
Why?
Anticholesteremic Agents
1
2007
34
0.070
Why?
Statistics, Nonparametric
4
2009
206
0.070
Why?
Gastric Outlet Obstruction
1
2007
2
0.070
Why?
Resistin
1
2007
6
0.070
Why?
Pain Measurement
2
2019
327
0.070
Why?
Gastrointestinal Neoplasms
1
2007
31
0.070
Why?
Fibroblasts
2
2019
377
0.070
Why?
Multivariate Analysis
2
2014
902
0.070
Why?
Midwestern United States
1
2006
24
0.070
Why?
Thiazolidinediones
1
2006
50
0.070
Why?
Healthcare Disparities
1
2010
326
0.060
Why?
Hospital Mortality
2
2021
841
0.060
Why?
Biopsy, Fine-Needle
2
2018
61
0.060
Why?
United States
4
2020
7390
0.060
Why?
Gene Expression
2
2019
809
0.060
Why?
Early Detection of Cancer
2
2023
266
0.060
Why?
Mice, Obese
4
2006
80
0.060
Why?
Radiography, Abdominal
1
2005
27
0.060
Why?
Case-Control Studies
2
2021
1051
0.060
Why?
Dissection
1
2005
45
0.060
Why?
Hypoglycemic Agents
1
2006
192
0.060
Why?
Cystadenoma
1
2004
6
0.060
Why?
Intestine, Small
1
2005
77
0.060
Why?
Magnetic Resonance Imaging
4
2019
2060
0.060
Why?
Cohort Studies
4
2011
2374
0.060
Why?
Pylorus
1
2004
10
0.060
Why?
Acetylcholine
4
2006
41
0.060
Why?
Myocytes, Smooth Muscle
1
2004
57
0.060
Why?
Adenoma, Islet Cell
1
2003
4
0.060
Why?
Preoperative Period
2
2017
61
0.060
Why?
Chemotherapy, Adjuvant
2
2017
75
0.050
Why?
Recurrence
3
2014
603
0.050
Why?
Severity of Illness Index
2
2022
1479
0.050
Why?
Mice, Inbred NOD
1
2004
516
0.050
Why?
Carcinoma
1
2004
115
0.050
Why?
Germ-Line Mutation
1
2023
43
0.050
Why?
Stents
1
2007
461
0.050
Why?
Muscle Contraction
2
2019
197
0.050
Why?
Diet
1
2006
497
0.050
Why?
Diabetes Mellitus
2
2004
515
0.050
Why?
Acute Disease
1
2023
660
0.050
Why?
Biomarkers
2
2019
1306
0.050
Why?
Ileum
1
2001
20
0.050
Why?
Organ Size
3
2007
164
0.050
Why?
Decompression
1
2021
1
0.050
Why?
Gastric Emptying
1
2021
6
0.050
Why?
North America
2
2012
106
0.050
Why?
Gastric Fistula
1
2020
4
0.040
Why?
Exocrine Pancreatic Insufficiency
1
2020
7
0.040
Why?
Splanchnic Circulation
1
2020
16
0.040
Why?
Propensity Score
1
2021
144
0.040
Why?
Heparin, Low-Molecular-Weight
1
2020
26
0.040
Why?
Carcinoma, Renal Cell
1
2001
83
0.040
Why?
Factor Xa Inhibitors
1
2020
34
0.040
Why?
Immunohistochemistry
2
2019
847
0.040
Why?
Kaplan-Meier Estimate
2
2012
396
0.040
Why?
Genotype
1
2002
617
0.040
Why?
Triglycerides
3
2007
231
0.040
Why?
Kidney Neoplasms
1
2001
126
0.040
Why?
Health Plan Implementation
1
2020
40
0.040
Why?
Herniorrhaphy
1
2020
69
0.040
Why?
Retreatment
1
2020
46
0.040
Why?
Leukocyte Count
1
2019
97
0.040
Why?
Odds Ratio
1
2022
745
0.040
Why?
Heparin
1
2020
111
0.040
Why?
Efficiency
1
2019
37
0.040
Why?
Cachexia
1
2019
9
0.040
Why?
Activin Receptors, Type II
1
2019
9
0.040
Why?
Colectomy
1
2020
104
0.040
Why?
Syndrome
1
2019
170
0.040
Why?
Body Weights and Measures
1
2019
33
0.040
Why?
Intraoperative Care
1
2019
36
0.040
Why?
Actuarial Analysis
2
1999
17
0.040
Why?
Lymphoma
1
2000
99
0.040
Why?
Muscular Atrophy
1
2019
25
0.040
Why?
Failure to Thrive
1
2019
7
0.040
Why?
Centralized Hospital Services
1
2018
5
0.040
Why?
Fatigue
1
2019
103
0.040
Why?
Genes, ras
1
1998
27
0.040
Why?
Nurses
1
2020
102
0.040
Why?
Reference Values
1
2019
326
0.040
Why?
Quality of Life
2
2023
1137
0.040
Why?
Islets of Langerhans
1
2020
271
0.040
Why?
Genes, p53
1
1998
52
0.040
Why?
Muscle Fibers, Skeletal
1
2019
87
0.040
Why?
Hospitals, High-Volume
1
2018
32
0.040
Why?
Renal Insufficiency
1
2019
65
0.040
Why?
Age Factors
2
2016
1504
0.040
Why?
Heterozygote
1
2019
161
0.040
Why?
Chronic Pain
1
2020
134
0.040
Why?
Anticoagulants
1
2022
477
0.040
Why?
Progesterone
1
1999
158
0.040
Why?
Interstitial Cells of Cajal
1
2017
2
0.040
Why?
Proto-Oncogene Proteins c-sis
1
2017
5
0.040
Why?
Genetic Testing
1
2019
126
0.040
Why?
Heme Oxygenase-1
1
2017
18
0.040
Why?
Stem Cell Factor
1
2017
26
0.040
Why?
Clinical Decision-Making
1
2019
146
0.040
Why?
Program Evaluation
1
2020
470
0.040
Why?
Neoplasm Grading
1
2017
79
0.040
Why?
Analgesics, Opioid
1
2022
483
0.040
Why?
Anoctamin-1
1
2017
16
0.040
Why?
Conversion to Open Surgery
1
2017
7
0.040
Why?
Obesity, Morbid
1
2019
92
0.040
Why?
Double-Blind Method
1
2019
715
0.040
Why?
Disease Management
1
2019
221
0.040
Why?
Failure to Rescue, Health Care
1
2017
4
0.030
Why?
Disease Models, Animal
2
2019
2050
0.030
Why?
Endoscopy
1
2017
98
0.030
Why?
Random Allocation
2
2012
192
0.030
Why?
Fatty Acids, Nonesterified
2
2007
56
0.030
Why?
Phospholipids
2
2007
78
0.030
Why?
Choledochal Cyst
1
1996
3
0.030
Why?
Enzyme-Linked Immunosorbent Assay
2
2007
446
0.030
Why?
Universities
1
2017
144
0.030
Why?
Neoplasm Proteins
1
2017
277
0.030
Why?
Dogs
2
2012
314
0.030
Why?
Surgery Department, Hospital
1
2015
20
0.030
Why?
Kidney Diseases
1
2017
169
0.030
Why?
Quality of Health Care
1
2019
510
0.030
Why?
Neuropeptide Y
2
2006
12
0.030
Why?
Cell Line, Tumor
1
2019
1370
0.030
Why?
Histamine H2 Antagonists
1
2015
10
0.030
Why?
Jejunostomy
2
2010
7
0.030
Why?
National Institutes of Health (U.S.)
1
2015
111
0.030
Why?
Alkaline Phosphatase
1
2014
46
0.030
Why?
Radiotherapy, Adjuvant
2
2010
58
0.030
Why?
Hospitalization
1
2022
1290
0.030
Why?
Early Termination of Clinical Trials
1
2014
5
0.030
Why?
Early Diagnosis
1
2014
92
0.030
Why?
False Negative Reactions
1
2014
40
0.030
Why?
Neurotransmitter Agents
2
2004
41
0.030
Why?
False Positive Reactions
1
2014
76
0.030
Why?
Drug Resistance
2
2004
95
0.030
Why?
Quality Improvement
1
2017
416
0.020
Why?
Peptide Fragments
2
2006
400
0.020
Why?
Decision Support Techniques
1
2014
179
0.020
Why?
RNA, Messenger
1
2017
1465
0.020
Why?
Reproducibility of Results
2
2007
1561
0.020
Why?
Sciuridae
2
2001
3
0.020
Why?
Randomized Controlled Trials as Topic
1
1995
677
0.020
Why?
Ligation
1
2011
33
0.020
Why?
Heart Failure
1
2019
853
0.020
Why?
Health Care Costs
1
2012
203
0.020
Why?
Practice Guidelines as Topic
1
2015
705
0.020
Why?
Algorithms
2
2010
976
0.020
Why?
Minimally Invasive Surgical Procedures
1
2011
98
0.020
Why?
Down-Regulation
2
2001
306
0.020
Why?
Fluorouracil
1
2010
55
0.020
Why?
Feasibility Studies
1
2012
525
0.020
Why?
Florida
1
2010
42
0.020
Why?
Blotting, Western
2
2001
584
0.020
Why?
Analysis of Variance
1
2011
589
0.020
Why?
Contraindications
1
2009
46
0.020
Why?
Signal Transduction
1
2019
2902
0.020
Why?
Academic Medical Centers
1
2011
306
0.020
Why?
Postoperative Period
1
2009
127
0.020
Why?
Cost-Benefit Analysis
1
2010
297
0.020
Why?
Poverty
1
2010
281
0.020
Why?
Ezetimibe
1
2007
6
0.020
Why?
Cholesterol Esters
1
2007
10
0.020
Why?
Viscera
1
2007
10
0.020
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2007
74
0.020
Why?
Sodium
1
2007
60
0.020
Why?
Osmolar Concentration
1
2007
88
0.020
Why?
Cholinergic Agents
1
2006
9
0.020
Why?
Decision Making
1
2010
395
0.020
Why?
Angiography
1
2007
146
0.020
Why?
Comorbidity
1
2010
1078
0.020
Why?
Butter
1
2006
1
0.020
Why?
Radiography, Interventional
1
2007
72
0.020
Why?
Mice, Inbred Strains
1
2006
179
0.020
Why?
Barium Sulfate
1
2005
18
0.020
Why?
Enema
1
2005
12
0.020
Why?
Mice, Mutant Strains
1
2004
297
0.010
Why?
Spleen
1
2005
480
0.010
Why?
Phenotype
1
2007
1137
0.010
Why?
Vacuoles
1
2003
26
0.010
Why?
Cytokines
1
2007
912
0.010
Why?
Diabetes Complications
1
2003
100
0.010
Why?
Dose-Response Relationship, Drug
1
2004
806
0.010
Why?
Contrast Media
1
2005
408
0.010
Why?
Receptors, Vasoactive Intestinal Peptide
1
2001
1
0.010
Why?
Nitroarginine
1
2001
2
0.010
Why?
Nitric Oxide Synthase Type I
1
2001
6
0.010
Why?
Iron, Dietary
1
2001
9
0.010
Why?
Vasoactive Intestinal Peptide
1
2001
23
0.010
Why?
Electric Stimulation
1
2001
131
0.010
Why?
Cytodiagnosis
1
2001
44
0.010
Why?
Hemoglobins
1
2001
133
0.010
Why?
Vincristine
1
2000
25
0.010
Why?
Cyclophosphamide
1
2000
75
0.010
Why?
Prednisone
1
2000
85
0.010
Why?
Doxorubicin
1
2000
97
0.010
Why?
Lymphoma, Large B-Cell, Diffuse
1
2000
65
0.010
Why?
Diabetes Mellitus, Type 1
1
2004
605
0.010
Why?
Enzyme Inhibitors
1
2001
349
0.010
Why?
West Virginia
1
1998
6
0.010
Why?
Linear Models
1
1999
402
0.010
Why?
Cause of Death
1
1999
210
0.010
Why?
Inflammatory Bowel Diseases
1
1999
95
0.010
Why?
Liver Transplantation
1
1999
207
0.010
Why?
Tumor Suppressor Protein p53
1
1998
289
0.010
Why?
Diagnostic Imaging
1
1999
243
0.010
Why?
Child
1
1999
4174
0.010
Why?
Nakeeb's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (466)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_